Citation Impact
Citing Papers
Prevalence and risk of violence against children with disabilities: a systematic review and meta-analysis of observational studies
2012 Standout
Haloperidol dose for the acute phase of schizophrenia
2002
Neurocognitive Deficits and Functional Outcome in Schizophrenia: Are We Measuring the "Right Stuff"?
2000 Standout
The association between adaptive and cognitive deficits in geriatric chronic schizophrenic patients
1997
Time Course and Biologic Correlates of Treatment Response in First-Episode Schizophrenia
1993
Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients
2009
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
Is cholinergic sensitivity a genetic marker for the affective disorders?
1994
DESIGN AND REPORTING MODIFICATIONS IN INDUSTRY-SPONSORED COMPARATIVE PSYCHOPHARMACOLOGY TRIALS
2002
Gammahydroxybutyrate: An endogenous regulator of energy metabolism
1989
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Muscarinic Supersensitivity and Impaired Receptor Desensitization in G Protein–Coupled Receptor Kinase 5–Deficient Mice
1999 StandoutNobel
The D2 Receptor Occupancy Profile of Loxapine Determined Using PET
1996
Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia
1995
The emotional dog and its rational tail: A social intuitionist approach to moral judgment.
2001 Standout
Descending control of pain
2002 Standout
PHARMACOLOGICAL ASPECTS OF HUMAN AND CANINE NARCOLEPSY
1997
Ego depletion and the strength model of self-control: A meta-analysis.
2010 Standout
Schizophrenia
2009 Standout
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
2005 Standout
Volume of the cingulate and outcome in schizophrenia
2004
Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex
2002 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective
2005 Standout
Crime Victimization in Adults With Severe Mental Illness
2005
Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication
1996
The Neural Basis of Addiction: A Pathology of Motivation and Choice
2005 Standout
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
2005 Standout
New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine
1995
CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia
1993
Short-Term Triazolam Use Improves Nocturnal Sleep of Narcoleptics
1992
The role of the posterior cingulate cortex in cognition and disease
2013 Standout
In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders
2009
The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis
2010 Standout
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Independent frontal-system deficits in schizophrenia: cognitive, clinical, and adaptive implications
1999
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Dose Response and Dose Equivalence of Antipsychotics
2004
Integrating psychological and neurobiological considerations regarding the development and maintenance of specific Internet-use disorders: An Interaction of Person-Affect-Cognition-Execution (I-PACE) model
2016 Standout
Elevated Interleukin-6 in the Cerebrospinal Fluid of a Previously Delineated Schizophrenia Subtype
2003
Narcolepsy in orexin Knockout Mice
1999 Standout
Selective reductions in prefrontal glucose metabolism in murderers
1994
The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults
1993 Standout
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
2000 Standout
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 Standout
The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene
1999 Standout
How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment
2001
THE γ-HYDROXYBUTYRATE SIGNALLING SYSTEM IN BRAIN: ORGANIZATION AND FUNCTIONAL IMPLICATIONS
1997
Neuronal and behavioural abnormalities in striatal function in DARPP‐32‐mutant mice
1999 StandoutNobel
THE NORTHWICK PARK "FUNCTIONAL" PSYCHOSIS STUDY: DIAGNOSIS AND TREATMENT RESPONSE
1988
Phantom auditory perception (tinnitus): mechanisms of generation and perception
1990 Standout
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
2011 Standout
The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function
2003 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Neurocircuitry of Addiction
2009 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Cocaine abusers show a blunted response to alcohol intoxication in limbic brain regions
2000
Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men.
1997
GABA in plants: just a metabolite?
2004 Standout
Industry sponsorship and research outcome
2012 Standout
Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum
1996
Alcohol activates the cerebral reward system in man.
1998
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Prophylaxis of Bipolar Affective Disorders
1990
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus
1996 Standout
Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments
1995 Standout
Synthesis, structure and properties of polyhydroxyalkanoates: biological polyesters
2000 Standout
Clinical significance of the sparteine/debrisoquine oxidation polymorphism
1989
Regional Brain Metabolic Response to Lorazepam in Alcoholics during Early and Late Alcohol Detoxification
1997
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study
1996
How antipsychotics work—From receptors to reality
2006
Haloperidol dose for the acute phase of schizophrenia
2013
Optimal Haloperidol Dosage in First-Episode Psychosis
1999
Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator γ‐hydroxybutyrate
2003
About Sleep's Role in Memory
2013 Standout
Dopamine in schizophrenia: a review and reconceptualization
1991 Standout
The Physiology of Willpower: Linking Blood Glucose to Self-Control
2007
Pharmacotherapy of first-episode schizophrenia
1998
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
Recovery of brain glucose metabolism in detoxified alcoholics
1994
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
1992 Standout
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Positron Emission Tomography Reveals Elevated D 2 Dopamine Receptors in Drug-Naive Schizophrenics
1986 Science
Industry sponsorship and research outcome
2017 Standout
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
2006 Standout
Creatine and Creatinine Metabolism
2000 Standout
Dopamine Metabolism in the Cerebrospinal Fluid of Drug-Free Schizophrenic Patients With and Without Cortical Atrophy
1986
Works of Jack Hirschowitz being referenced
The Dose Reduction in Schizophrenia (DORIS) study: a final report
1997
Early response to haloperidol treatment in chronic schizophrenia
1993
Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: Effects of typical neuroleptics on the brief psychiatric rating scale
1996
Single- vs Multiple-Dose Pharmacokinetics of Clozapine in Psychiatric Patients
1990
Challenges for Psychiatry in Serving Homeless People With Psychiatric Disorders
2003
Drug response patterns as a basis of nosology for the mood-incongruent psychoses (the schizophrenias)
1988
Acute effects of ethanol on regional brain glucose metabolism and transport
1990
Effect of haloperidol dose on iodine-123-IBZM brain SPECT imaging in schizophrenic patients.
1997
Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphine
1986
Lithium response in good prognosis schizophrenia
1980
Further evidence of a dose-response threshold for haloperidol in psychosis
1995
Thioridazine Effect on Desipramine Plasma Levels
1983
Down-regulation of central dopamine receptors in schizophrenia
1985
The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy.
1985
Growth hormone levels and lithium ratios as predictors of success of lithium therapy in schizophrenia
1982
Clinical response and plasma haloperidol levels in schizophrenia
1983
Haloperidol plasma and red blood cell levels and clinical antipsychotic response.
1984
Morning amnestic effects of triazolam.
1986
Physostigmine and lithium response in the schizophrenias
1981
Plasma haloperidol levels and clinical response: confounding variables.
1985
Clonazepam treatment of five lithium-refractory patients with bipolar disorder
1989
Membrane abnormalities in the psychoses and affective disorders
1984
Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings
1996